首页> 美国卫生研究院文献>International Journal of Molecular Medicine >IL-1β impedes the chondrogenic differentiation of synovial fluid mesenchymal stem cells in the human temporomandibular joint
【2h】

IL-1β impedes the chondrogenic differentiation of synovial fluid mesenchymal stem cells in the human temporomandibular joint

机译:IL-1β抑制人颞下颌关节滑液间充质干细胞的软骨分化

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Mesenchymal stem cell-based therapy has great therapeutic potential for temporomandibular joint (TMJ) cartilage repair. However, the behavior of mesenchymal stem cells in the inflammatory milieu following their delivery remains poorly understood. Synovial fluid-derived mesenchymal stem cells (SFMSCs) are a promising resource for TMJ cartilage repair, as they are easily obtained from patients with TMJ disorders (TMD). In this study, we obtained SFMSCs from patients with TMD and expanded them in vitro; we then stimulated the cells with interleukin (IL)-8, IL-1β, IL-6, IL-10, tumor necrosis factor (TNF)-α and IL-12p. The cells expressed CD90, CD44, CD105 and CD73, and were negative for CD45, CD34, CD11b, CD19 and HLA-DR. They could be induced to differentiate into osteogenic, chondrogenic, adipogenic and neurogenic lineages in vitro. Only the levels of IL-6 and IL-8 were upregulated significantly following stimulation with IL-8, IL-1β, IL-6, IL-10, TNF-α and IL-12p. Furthermore, IL-6 and IL-8 expression was driven mainly by IL-1β-dependent nuclear factor-κB (NF-κB) pathway activation, and was independent of IL-8, IL-6, IL-10, TNF-α and IL-12p. IL-6 and IL-8 expression was inhibited completely by treatment with the NF-κB inhibitor, BAY11-7082. SRY-box 9 (SOX9) was downregulated and matrix metalloproteinase (MMP)13 was upregulated upon chondrogenic differentiation induced in the cells also exposed to IL-1β. Sulfated glycosaminoglycan production was also reduced upon chondrogenic differentiation in the presence of IL-6, but not IL-8. Thus, IL-1β in the inflammatory milieu is crucial in regulating SFMSCs. In doing so, IL-1β impedes the chondrogenic differentiation of SFMSCs. The upregulation of IL-6 and NF-κB pathway activation also contribute to this biological behavior. The findings of our study indicate the potential adverse effects of IL-1β on the chondrogenic differentiation of SFMSCs, and may thus provide new insight into the pathogenesis of TMD.
机译:基于间充质干细胞的疗法在颞下颌关节(TMJ)软骨修复中具有巨大的治疗潜力。然而,在炎性环境中,间质干细胞在其递送后的行为仍知之甚少。滑液来源的间充质干细胞(SFMSC)是TMJ软骨修复的一种有前途的资源,因为它们很容易从患有TMJ障碍(TMD)的患者中获得。在这项研究中,我们从TMD患者中获得了SFMSC,并在体外对其进行了扩增。然后我们用白介素(IL)-8,IL-1β,IL-6,IL-10,肿瘤坏死因子(TNF)-α和IL-12p刺激细胞。细胞表达CD90,CD44,CD105和CD73,并且对CD45,CD34,CD11b,CD19和HLA-DR呈阴性。可以诱导它们在体外分化为成骨,成软骨,成脂和神经源性谱系。在用IL-8,IL-1β,IL-6,IL-10,TNF-α和IL-12p刺激后,仅IL-6和IL-8的水平显着上调。此外,IL-6和IL-8的表达主要受IL-1β依赖性核因子-κB(NF-κB)途径激活的驱动,并且独立于IL-8,IL-6,IL-10,TNF-α和IL-12p。 IL-6和IL-8表达被NF-κB抑制剂BAY11-7082处理完全抑制。在也暴露于IL-1β的细胞中诱导软骨分化时,SRY-box 9(SOX9)被下调,基质金属蛋白酶(MMP)13被上调。在存在IL-6(而非IL-8)的情况下,软骨分化后硫酸化糖胺聚糖的产生也会减少。因此,炎症环境中的IL-1β在调节SFMSC中至关重要。在这种情况下,IL-1β阻碍了SFMSC的软骨分化。 IL-6和NF-κB途径激活的上调也有助于这种生物学行为。我们研究的结果表明IL-1β对SFMSCs软骨分化的潜在不利影响,从而可能为TMD的发病机理提供新的认识。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号